Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Xenova Group PLC (XEN)

  Print      Mail a friend

Friday 06 April, 2001

Xenova Group PLC

Offer Update

Xenova Group PLC
6 April 2001

Time embargoed until 7.00 a.m. on 6 April 2001

Not for release, publication or distribution in or into the United States,
Canada, Australia or Japan

                         Xenova Group plc ('Xenova')

      Recommended Merger Offer for Cantab Pharmaceuticals plc ('Cantab')

  Merger Offer Declared Unconditional in all Respects and Changes to Xenova

Xenova is pleased to announce that, all of the conditions of the Merger Offer
having been satisfied or waived, the Merger Offer is now declared
unconditional in all respects (subject only to the New Xenova Shares being
admitted to listing on the Official List of the UK Listing Authority and to
trading on the London Stock Exchange's market for listed securities, which is
expected to commence at 8.00 a.m. on 9 April 2001).

By 3.00 p.m. on 5 April 2001, valid acceptances of the Merger Offer had been
received in respect of 32,382,836 Cantab Shares, representing approximately
72.91 per cent. of the existing issued share capital of Cantab. The total
number of acceptances includes acceptances in respect of 196,006 Cantab Shares
(representing approximately 0.44 per cent. of the existing issued share
capital of Cantab) which were the subject of irrevocable undertakings to
accept the Merger Offer from Cantab Directors.

Settlement of the consideration to which Cantab Shareholders are entitled will
be effected by 20 April 2001 in the case of valid acceptances already
received, and within 14 days of receipt in the case of valid acceptances
received after today's date and while the Merger Offer remains open for

The Merger Offer will remain open for acceptance until further notice. At
least 14 days' notice will be given before the Merger Offer is closed.

As stated in the Offer Document, Xenova will procure the cancellation of the
listing of the Cantab Shares on the Official List and of trading in Cantab
Shares on the London Stock Exchange's market for listed securities. Such
cancellation of listing and trading will take place on 9 May 2001.

As and when Xenova receives acceptances in respect of 90 per cent. in value of
the Cantab Shares to which the Merger Offer relates, Xenova will seek to
acquire compulsorily any outstanding Cantab Shares to which the Merger Offer
relates pursuant to sections 428 to 430F of the Companies Act 1985.

Save as disclosed below, neither Xenova nor any person deemed to be acting in
concert with it held any Cantab Shares or rights over Cantab Shares on 31
October 2000, the date immediately prior to the commencement of the Merger
Offer Period. Save as disclosed herein, neither Xenova nor any person deemed
to be acting in concert with it has acquired or agreed to acquire any Cantab
Shares or rights over Cantab Shares since the Merger Offer Period commenced.

As at 31 October 2000, the last business day immediately prior to the
commencement of the Merger Offer Period, Nomura, which is deemed to be acting
in concert with Xenova, held 5,715 Cantab Shares (representing approximately
0.013 per cent. of the existing issued share capital of Cantab).

Simon Duffy, Gerard Fairtlough, Nicholas Hart, Stephen Inglis and John St
Clair Roberts currently directors of Cantab, have today been appointed
directors of Xenova. The resignation of Paul Bevan as a non-executive director
of Xenova has also been accepted today.

Application has been made to the UK Listing Authority for up to 69,947,963 New
Xenova Shares to be admitted to the Official List. Application has also been
made to the London Stock Exchange for up to 69,947,963 New Xenova Shares to be
admitted to trading on the London Stock Exchange's market for listed
securities. Admission of the New Xenova Shares to listing on the Official List
and to trading on the London Stock Exchange's market for listed securities is
expected to become effective and dealings for normal settlement in New Xenova
Shares are expected to commence at 8.00 a.m. on 9 April 2001.

Terms defined in the Offer Document dated 1 March 2001 have the same meaning
in this announcement.

David Oxlade, Xenova                                    01753 706600
David Porter, Nomura                                    020 7521 2000
Fiona Noblet, Financial Dynamics                        020 7831 3113

Nomura International plc, which is regulated in the United Kingdom by The
Securities and Futures Authority Limited, is acting for Xenova and no one else
in connection with the Merger Offer and will not be responsible to anyone
other than Xenova for providing the protections afforded to customers of
Nomura or for providing advice in relation to the Merger Offer.

The Merger Offer is not being made, directly or indirectly, in or into, or by
use of the mails of, or by any means or instrumentality (including, without
limitation, facsimile transmissions, telex, telephone or internet) of
interstate or foreign commerce of, or any facilities of a securities exchange
of, the United States nor is it being made, directly or indirectly, in or
into, Canada, Australia or Japan unless an exemption under any applicable laws
is available.

This announcement has been approved by Nomura for the purposes of Section 57
of the Financial Services Act 1986.



a d v e r t i s e m e n t